loader

World Tenders & Procurement Opportunities

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – TBE vaccine and rabies vaccine - 254089-2024

World Biggest Tenders Source

This tender with title General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – TBE vaccine and rabies vaccine - 254089-2024 has been published on Bidding Source portal dated 01 May 2024 for the country of Germany. It has been categorized on Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents & Antineoplastic agents & Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – TBE vaccine and rabies vaccine - 254089-2024
Invitation for Bids
Germany
1 May 2024
3 Jun 2024
English
Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents , Antineoplastic agents , Antineoplastic and immunomodulating agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 6002636912-Diverse Impfstoffe - 296319-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient glatiramer acetate (ATC code: L03AX13), with the exception of the dosage form pre-filled pen (PEN). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (ATC-Code: L04AB06). -- <h6>Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient golimumab (ATC code: L04AB06).</h6> Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient nilotinib (ATC code: L01EA03). -- <h6>Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Nilotinib (ATC-Code: L01EA03).</h6> Germany Conclusion of a non-exclusive discount agreement in accordance with § 130a Paragraph 8 SGB V for medicinal products with the active ingredient rituximab (ATC code: L01FA01). Germany Germany - Conclusion of a non-exclusive discount agreement in accordance with § 130a Paragraph 8 SGB V for drugs with the active ingredient octreotide, in a dosage form with delayed release behavior ATC code: H01CB02 -- <br><b>Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Octreotid, in einer Darreichungsform mit verzögertem Freisetzungsverhalten ATC-Code:H01CB02</b> Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Dasatinib (ATC-Code: L01EA02). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Pegfilgrastim (ATC-Code: L03AA13). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (ATC-Code: L03AA02). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Goserelin (ATC-Code: L02AE03). -- Antineoplastic and immunomodulating agents Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans